Citigroup’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,100
| Closed | -$4.72M | – | 6130 |
|
|
2025
Q4 | $4.72M | Buy |
+10,100
| New | +$4.69M | ﹤0.01% | 2054 |
|
|
2025
Q2 | – | Sell |
-130,000
| Closed | -$44.9M | – | 5754 |
|
|
2025
Q1 | $44.9M | Buy |
130,000
+122,000
| +1,525% | +$39.2M | 0.02% | 586 |
|
|
2024
Q4 | $2.4M | Hold |
8,000
| – | – | ﹤0.01% | 2662 |
|
|
2024
Q3 | $3.25M | Sell |
8,000
-38,900
| -83% | -$14.2M | ﹤0.01% | 2223 |
|
|
2024
Q2 | $15.1M | Buy |
46,900
+12,700
| +37% | +$4.13M | 0.01% | 1037 |
|
|
2024
Q1 | $11.4M | Sell |
34,200
-42,600
| -55% | -$13M | 0.01% | 1177 |
|
|
2023
Q4 | $20.8M | Buy |
76,800
+43,800
| +133% | +$10.8M | 0.01% | 839 |
|
|
2023
Q3 | $8.12M | Buy |
33,000
+11,000
| +50% | +$3.01M | 0.01% | 1203 |
|
|
2023
Q2 | $6.68M | Buy |
22,000
+4,000
| +22% | +$1.11M | ﹤0.01% | 1328 |
|
|
2023
Q1 | $4.75M | Sell |
18,000
-152,800
| -89% | -$38.8M | ﹤0.01% | 1535 |
|
|
2022
Q4 | $41M | Buy |
170,800
+46,000
| +37% | +$10.3M | 0.03% | 469 |
|
|
2022
Q3 | $22.9M | Buy |
+124,800
| New | +$24.9M | 0.02% | 721 |
|
|
2021
Q2 | – | Sell |
-108,000
| Closed | -$20.3M | – | 6239 |
|
|
2021
Q1 | $20.3M | Buy |
108,000
+15,400
| +17% | +$2.72M | 0.01% | 942 |
|
|
2020
Q4 | $15.2M | Sell |
92,600
-25,300
| -21% | -$3.7M | 0.01% | 1231 |
|
|
2020
Q3 | $14.7M | Buy |
117,900
+33,800
| +40% | +$4.18M | 0.01% | 1095 |
|
|
2020
Q2 | $8.16M | Sell |
84,100
-19,300
| -19% | -$2.01M | 0.01% | 1464 |
|
|
2020
Q1 | $9.29M | Sell |
103,400
-7,300
| -7% | -$945K | 0.01% | 1212 |
|
|
2019
Q4 | $16.4M | Buy |
110,700
+28,400
| +35% | +$3.81M | 0.01% | 1103 |
|
|
2019
Q3 | $9.91M | Buy |
82,300
+36,800
| +81% | +$4.76M | 0.01% | 1404 |
|
|
2019
Q2 | $6.15M | Buy |
45,500
+15,100
| +50% | +$1.91M | 0.01% | 1800 |
|
|
2019
Q1 | $3.96M | Sell |
30,400
-41,000
| -57% | -$5.51M | ﹤0.01% | 1996 |
|
|
2018
Q4 | $8.89M | Sell |
71,400
-2,100
| -3% | -$282K | 0.01% | 1347 |
|
|
2018
Q3 | $10.2M | Sell |
73,500
-16,700
| -19% | -$2.08M | 0.01% | 1274 |
|
|
2018
Q2 | $9.26M | Buy |
90,200
+6,800
| +8% | +$688K | 0.01% | 1337 |
|
|
2018
Q1 | $8.09M | Sell |
83,400
-49,300
| -37% | -$4.78M | 0.01% | 1398 |
|
|
2017
Q4 | $11.7M | Buy |
132,700
+45,700
| +53% | +$3.67M | 0.01% | 1180 |
|
|
2017
Q3 | $6.92M | Sell |
87,000
-9,200
| -10% | -$740K | 0.01% | 1492 |
|
|
2017
Q2 | $8.39M | Sell |
96,200
-246,700
| -72% | -$20.9M | 0.01% | 1278 |
|
|
2017
Q1 | $30.5M | Buy |
342,900
+192,800
| +128% | +$16.1M | 0.03% | 562 |
|
|
2016
Q4 | $11.1M | Buy |
150,100
+101,300
| +208% | +$7.59M | 0.01% | 1115 |
|
|
2016
Q3 | $3.69M | Sell |
48,800
-19,700
| -29% | -$1.51M | ﹤0.01% | 1952 |
|
|
2016
Q2 | $5.28M | Buy |
68,500
+4,700
| +7% | +$371K | 0.01% | 1534 |
|
|
2016
Q1 | $4.98M | Buy |
63,800
+32,300
| +103% | +$2.26M | 0.01% | 1563 |
|
|
2015
Q4 | $2.13M | Sell |
31,500
-26,700
| -46% | -$1.86M | ﹤0.01% | 2435 |
|
|
2015
Q3 | $4.5M | Sell |
58,200
-125,300
| -68% | -$11.1M | ﹤0.01% | 1748 |
|
|
2015
Q2 | $16.6M | Buy |
183,500
+123,300
| +205% | +$9.88M | 0.01% | 892 |
|
|
2015
Q1 | $4.53M | Sell |
60,200
-470,800
| -89% | -$33.8M | ﹤0.01% | 1816 |
|
|
2014
Q4 | $39M | Buy |
531,000
+77,200
| +17% | +$5.43M | 0.03% | 498 |
|
|
2014
Q3 | $32M | Buy |
453,800
+141,500
| +45% | +$9.35M | 0.03% | 569 |
|
|
2014
Q2 | $17.6M | Buy |
312,300
+260,000
| +497% | +$13.7M | 0.02% | 876 |
|
|
2014
Q1 | $2.75M | Sell |
52,300
-68,800
| -57% | -$3.42M | ﹤0.01% | 2148 |
|
|
2013
Q4 | $5.78M | Sell |
121,100
-54,900
| -31% | -$2.54M | 0.01% | 1674 |
|
|
2013
Q3 | $7.52M | Buy |
176,000
+59,600
| +51% | +$2.33M | 0.01% | 1415 |
|
|
2013
Q2 | $4.2M | Buy |
+116,400
| New | +$4.5M | ﹤0.01% | 1778 |
|
Other funds holding HCA
VCM
VPM
Citigroup's HCA Position: Q1 2026 in Review
Citigroup reduced its HCA Healthcare (HCA) stake by 0.99% in Q1 2026, selling an estimated $1.18M and leaving 233,479 shares worth $110M. The position accounts for 0.05% of the portfolio, ranked #375.
Citigroup first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Citigroup held 233,479 shares of HCA Healthcare worth $110M as of Q1 2026.
- Citigroup sold 2,343 HCA Healthcare shares in Q1 2026, an estimated $1.18M.
- HCA Healthcare made up 0.05% of Citigroup's portfolio in Q1 2026, its #375 holding.
- Citigroup first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.